SUSMED,Inc. (4263) Stock Statistics & Valuation Metrics

SUSMED,Inc. has a market cap or net worth of ¥9.57B. The enterprise value is ―.

SUSMED,Inc. has 16,812,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

SUSMED,Inc.’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -7.94%.

The current PE Ratio of SUSMED,Inc. is -25.45. SUSMED,Inc.’s PEG ratio is 0.28.

In the last 12 months, SUSMED,Inc. had revenue of 342.58M and earned -357.42M in profits. Earnings per share was -21.41.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

SUSMED,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

SUSMED,Inc. upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.

SUSMED,Inc. as a current ratio of 15.24, with Debt / Equity ratio of 0.00%

In the past 12 months, SUSMED,Inc. has paid 1.21M in taxes.

SUSMED,Inc. EV to EBITDA ratio is -11.84, with an EV/FCF ratio of -17.71.

SUSMED,Inc. has ¥4.56B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -¥4.56B billion.

Gross margin is 92.00%, with operating margin of -106.54%, and net profit margin of -104.33%.

The average price target for SUSMED,Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―